Connect with us

Business

High Court rules Baroness Mone-linked company breached £122m Covid contract

Published

on

High Court rules Baroness Mone-linked company breached £122m Covid contract


Rachel ClunBusiness reporter

Getty Images Baroness Michelle Mone in the House of Lords wearing ceremonial robes. She has blonde hair.Getty Images

A company linked to peer Baroness Mone and her husband Doug Barrowman has been ordered to pay £122m in damages after a judge ruled it breached a government contract for the supply of personal protective equipment (PPE) during the Covid pandemic.

The Department of Health and Social Care sued PPE Medpro over claims the medical gowns it supplied did not comply with relevant healthcare standards.

The High Court ruled Medpro failed to prove whether or not its surgical gowns, which were to be used by NHS workers, had undergone a validated sterilisation process.

Chancellor Rachel Reeves said it was beyond her powers for Baroness Mone to be stripped of her peerage.

But speaking to Matt Chorley on BBC Radio 5 Live, Reeves said: “I hope she won’t be back in the House of Lords.”

Peerages can only be removed by an act of Parliament. While a life peerage cannot be relinquished, Baroness Mone could choose to resign from being a member of the House of Lords.

Reeves said she would “do everything” in her power “to get that money back” and that the money belongs “in our schools, in our hospitals and in our communities”.

During the outbreak of the Covid pandemic in 2020, the government scrambled to secure supplies of PPE as the country went into lockdown and hospitals across the country were reporting shortages of clothing and accessories to protect medics from the virus.

In May that year, PPE Medpro was set up by a consortium led by Baroness Mone’s husband, Doug Barrowman, and won its first government contract to supply masks through a so-called VIP lane after being recommended by Baroness Mone.

The judgement said the government later ordered 25 million sterile gowns from Medpro, which were delivered in August and October 2020, after being manufactured in China.

However, just before Christmas that year, the Department of Health served the company with a notice rejecting the gowns and asking for a refund.

The judgement said the government decided it was “not satisfied that the gowns were contractually compliant” after inspecting them, and claimed subsequent tests conducted found “a number of them were not sterile”.

Paul Stanley KC, representing the government, told the trial that of 140 gowns that were tested, 103 failed.

It led to the government launching legal action in 2022 through the High Court, claiming the gowns did not comply with the agreed contract.

Medpro, however, argued it had complied with the contract and that the gowns were sterile.

Having previously denied gaining directly from the contracts, Baroness Mone, a former Conservative peer and lingerie tycoon, admitted in December 2023 that she stood to benefit from tens of millions of pounds of profit.

She also admitted to the BBC that she and her husband lied about their involvement with Medpro to avoid “press intrusion”.

The court found firm’s director Anthony Page called on his “big gun” – Baroness Mone – during negotiations in order to secure the gown contract.

In the court ruling on Wednesday, Justice Cockerill said the contract between Medpro and the government was “complex”, but found that the company did in fact have to demonstrate it had undertaken a “validated sterilisation process”.

“That was not complied with by Medpro,” she said. “It followed that Medpro had breached the contract.”

The ruling also said the gowns lacked the “notified body number” required to mark them as sterilised, and that Medpro had provided no evidence such a process had taken place.

Medpro had also argued that the government could have sold the gowns if it no longer wanted them, or repurposed to be used as non-sterile or isolation gowns.

During the case, the company said any lack of sterility or valid sterility marking “did not prevent the said gowns from being used within the NHS or from being sold to third parties outside of the EU”.

Justice Cockerill said there were problems with that argument, including the fact that the NHS did not need any more isolation gowns.

However, she noted that the DHSC did not effectively reject the gowns within a reasonable timeframe, and also dismissed the government’s claim for £8.65m in storage costs over lack of evidence.

The judge ruled the company must pay £121,999,219 in damages, plus interest, however, it remains unclear how Medpro will pay the fee, with the company appointing administrators the day before the court decision.

Its last set of accounts said it only had £666,025 of shareholders’ funds.

The court said the firm had until 15 October to pay the damages to the government.

Speaking after the judgement, Chancellor Rachel Reeves said the government was working with administrators and “all different authorities” to try and claim the money.

Doug Barrowman and Michelle Mone pictured during an interview with the BBC

‘A win for the establishment’

In response to the ruling, Baroness Mone said it was “shocking but all too predictable”.

“It is nothing less than an Establishment win for the Government in a case that was too big for them to lose,” she said in a social media post.

A spokesperson for Mr Barrowman described the ruling as “a travesty of justice”.

“[Mrs Justice Cockerill’s] judgment bears little resemblance to what actually took place during the month-long trial, where PPE Medpro convincingly demonstrated that its gowns were sterile,” the spokesperson added.

Baroness Mone was once described as one of the UK’s most successful businesswomen, creating the gel-padded Ultimo bra in the late 1990s.

In 2015, then-Prime Minister David Cameron made her the government’s “entrepreneurship tsar”, and shortly after she became a Conservative peer.

The next year she announced she was in a relationship with Mr Barrowman, a billionaire businessman who founded The Knocks Group of Companies and was a director of Aston Management Limited.

In December 2022, Baroness Mone sought a leave of absence from the House of Lords.

Neither Baroness Mone nor Mr Barrowman appeared in court for the decision.

A separate National Crime Agency (NCA) investigation into Medpro was launched in May 2021, into suspected criminal offences committed over the procurement of PPE.

An NCA spokesperson said on Wednesday its investigation was ongoing.



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

SoftBank reduces Ola Electric stake to 13.5% from 15.6% – The Times of India

Published

on

SoftBank reduces Ola Electric stake to 13.5% from 15.6% – The Times of India


BENGALURU: Masayoshi Son-led SoftBank Group pared its holding in Ola Electric Mobility to 13.5% from 15.6%, in what appears like a staggered exit from the electric 2-wheeler maker that was once among its marquee India bets. SVF II Ostrich (DE), a SoftBank affiliate and Ola Electric’s second-largest shareholder after founder Bhavish Aggarwal, sold 9.4 crore shares through open market transactions between Sept 3, 2025, and Jan 5, 2026, according to a regulatory filing.



Source link

Continue Reading

Business

How IMAX crushed other theater stocks in 2025

Published

on

How IMAX crushed other theater stocks in 2025


An Imax private screening for the movie “First Man” at an AMC theater in New York on Oct. 10, 2018.

Lars Niki | Getty Images Entertainment | Getty Images

The theatrical industry is in flux — and one stock is rising above the rest.

Imax saw its shares jump more than 44% in 2025, even before the company announced that it had generated a record $1.28 billion at the global box office for the year. Those ticket sales marked a more than 40% increase over 2024 and were 13% higher than its previous record set in 2019.

Meanwhile, shares of fellow theatrical stocks AMC, Cinemark and Marcus Theatres cratered in 2025. AMC was down more than 60%, Cinemark’s stock fell 25% and Marcus Corp., which operates theaters and hotel chains, slumped around 28%.

The sharp declines on Wall Street come as theater operators struggle to grapple with massive changes in the industry.

Domestic ticket sales have rebounded from the record lows posted during the Covid pandemic, but remain about 25% below the the record-breaking $11.8 billion collected in 2018. The 2025 box office fell short of the $9 billion analysts had projected heading into the year, signaling to industry watchdogs that post-pandemic hurdles could be more permanent than anticipated.

“In an environment where consumer spending headwinds and economic concerns forced consumers to be choiceful with their entertainment spending, streaming services continue to represent an attractive option,” Eric Wold, executive director of equity research at Texas Capital Securities, told CNBC.

At the same time that consumer habits have shifted toward the home entertainment market, Hollywood is producing fewer films.

A combination of Wall Street penny-pinching, studio mergers and lingering production shutdowns from the pandemic and dual labor strikes has led to a significant drop-off in the number of movies hitting theaters.

“I think investors are still struggling with, and frankly, what everyone within the industry is still trying to figure out is, what is the real new normal for box office?” said Robert Fishman, senior research analyst at MoffettNathanson.

The winnowing of theatrical has left Imax ahead of the pack.

Move toward premium

When the theatrical slate is thin, Imax benefits, because when moviegoers do decide to leave their couches they are opting more and more for premium large format experiences.

In 2025, more than 16% of tickets sold for domestic showtimes were for these types of theaters, according to data from EntTelligence. That’s up from 15% in 2024 and 13.8% in 2023.

Often called PLFs, premium large format auditoriums are considered an elevated viewing experience, with bigger screens and higher-quality sound systems and seating options — and they come with higher ticket prices.

In 2025, general movie tickets averaged $13.29 apiece, while PLF tickets went for around $17.65 each, EntTelligence data showed. For comparison, premium tickets in 2024 averaged around $16.88 apiece.

As Hollywood shifts toward producing more big-budget blockbuster features — while medium-to-low-budget films are more often sent to streaming — PLF screens will become increasingly important.

After all, the films that benefit the most from PLF ticket sales have been Hollywood’s biggest releases, as audiences want to see explosive action movies and dazzling spectacles in the most state-of-the-art locations.

ScreenX is the world’s first multi-projection cinema with an immersive 270 degree field of view.

CJ 4DPLEX

On the docket for 2026 is Disney’s “Star Wars: The Mandalorian and Grogu,” Universal and Christopher Nolan’s “The Odyssey,” Netflix and Greta Gerwig’s “Narnia” and Warner Bros. and Denis Villeneuve’s “Dune: Part Three.”

All of these films were shot with Imax film cameras and will have theatrical releases on Imax screens.

The company has forecast its 2026 global box office haul at a new record of $1.4 billion.

“We see no signs of slowing down given a very promising slate ahead and the consistency of our market share gains, as filmmakers, studios, and audiences worldwide continue to gravitate toward the Imax experience,” said Rich Gelfond, CEO of Imax, in a statement Wednesday.

As of the end of September, Imax had more than 1,700 locations and a backlog of 478 contracts to build Imax screens. Notably, Imax screens represent less than 1% of the total movie screens worldwide.

Putting up profits

AMC, Cinemark and Marcus all have premium large format movie screens as part of their suite of theaters as well and have invested in creating more of these spaces in their cinemas.

But the chains are playing a game of catch-up.

AMC, in addition to its existing partnership with Imax, has plans to add more Dolby Cinema theaters to its U.S.-based locations as well as Screen X and 4DX auditoriums globally. Cinemark, too, made investments in the last year to add more Screen X theaters to its portfolio.

Of course, these upgrades can be expensive. In the case of AMC, renovations prior to the pandemic saddled the company with billions in debt, which was exacerbated during Covid-related shutdowns. The company is still dealing with this debt load.

Working in Imax’s favor is the fact that the company is notably asset-light, meaning it has minimized its ownership of physical assets like buildings by leveraging its technology and partnering with other companies.

Instead of costly real estate leases, Imax makes deals with cinema chains to install its equipment into their auditoriums and then takes a share of the box office receipts for films screened in those theaters.

AMC, Cinemark, Marcus and other theater operators, on the other hand, have the financial burden of rent and utility payments, which are only partially offset by ticket sales that they split with studios. Concessions — popcorn, soda and specialty food — have become the means for these businesses to drum up enough funds to cover expenses.

But, if the production slate isn’t strong and cinemas don’t have enough content to draw in moviegoers, then profitability is at risk.

In the first quarter of 2025, all three cinema stocks posted net losses. Marcus and Cinemark rebounded to profitability in the second and third quarter, as the calendar of films improved, while AMC posted two more periods in the red.

Imax, on the other hand, was profitable in all three quarters. Through the first nine months of 2025, Imax reported net income of $43 million, up 67% from the same period in 2024.

The theater stocks will all report fourth-quarter results in the coming weeks as earnings reports roll out.



Source link

Continue Reading

Business

India outlook: Reforms put wind in its sails amid global headwinds; PMO’s Shaktikanta Das maps the road ahead – The Times of India

Published

on

India outlook: Reforms put wind in its sails amid global headwinds; PMO’s Shaktikanta Das maps the road ahead – The Times of India


India is at the cusp of a historic economic journey, with government policies and reforms giving the country “wind in its sails” even as global trade uncertainties intensify, Principal Secretary to the Prime Minister Shaktikanta Das said on Friday.Delivering the inaugural Bibek Debroy Memorial Lecture, Das said India has emerged stronger from successive global shocks and is now positioned to pursue sustained growth despite a fragmented global economic order, PTI reported.

‘India Outperforming Emerging Markets’: Economist On India’s 7.4% FY26 GDP Growth Estimates

Atmanirbharta as resilience, not isolation“At a time when the consensus that powered globalisation in past decades has frayed and multilateral cooperation has become harder to achieve, India has embraced Atmanirbharta as the overarching principle of our policies,” Das said.Clarifying the approach, he added: “Atmanirbharta is not being isolationist, but a strategy to build core competence and resilience. Economic Atmanirbharta means developing the capacity to produce critical goods and technologies at home and reducing over-reliance on foreign sources.”A self-reliant economy, backed by strong domestic capabilities and an autonomous foreign policy, provides India greater strength to sustain growth and navigate external challenges, he said. “Together, they ensure that India’s rise is resilient, sustainable and beneficial to us and to the world.”From global shocks to ‘wind in our sails’Das said India has successfully emerged from what appeared to be “perfect storms” triggered by multiple global shocks since the COVID-19 outbreak in 2020.“And now with the policies that the country has adopted, the wind is in our sails. We are indeed on our path to Viksit Bharat,” he said.India, he noted, stands at an inflection point where shifting geopolitical alignments and trade policies are reshaping the global economic landscape.“India stands today at the cusp of a historic journey — from being an incredible India to a credible India. There will be headwinds and challenges emanating from known and unknown sources,” Das said.Fragmenting world, India’s strategic responseDas flagged the strain on global institutions and multilateral frameworks, saying traditional multilateralism is increasingly being sidelined by geopolitical rivalries, protectionism and fragmentation.“Key international institutions are struggling to deliver on their mandates… Trade and supply chains, once seen as neutral conduits of globalisation, are increasingly being utilised as instrumentalities of disruption and dominance,” he said.Reshoring, friend-shoring and restricted technology flows are fragmenting global networks, reflecting broader geo-economic fragmentation, Das added.Against this backdrop, India’s approach is pragmatic. “India stands for a cooperative and rules-based global system; but at the same time, we are proactively forging partnerships and strategies to secure our national interest in a world where power is more diffused,” he said.“We, of course, acknowledge that the multilateral system must be revitalised, even as we adapt to new alignments,” Das added.



Source link

Continue Reading

Trending